Literature DB >> 23776815

Chromobacterium violaceum: A rare bacterium isolated from a wound over the scalp.

M Ravish Kumar1.   

Abstract

Infection due to Chromobacterium violaceum, a large motile gram-negative bacillus, is a rare entity that typically starts with a localized skin infection or localized lymphadenitis after contact with stagnant water or soil. It can progress to fulminating septicemia, with necrotizing metastatic lesions and multiple abscesses in the liver, lung, spleen, skin, lymph nodes, and brain, and result in fatal multiorgan failure. We report a case of a young male with a history of fall from a bike into stagnant water who subsequently developed C violaceum infection at the site of the sutured scalp wound.

Entities:  

Keywords:  Chromobacterium violaceum; saprophyte; septicemia

Year:  2012        PMID: 23776815      PMCID: PMC3657989          DOI: 10.4103/2229-516X.96814

Source DB:  PubMed          Journal:  Int J Appl Basic Med Res        ISSN: 2229-516X


INTRODUCTION

Chromobacterium violaceum is a large, motile, gram-negative bacillus having a single polar flagellum and, usually, one or two lateral flagella. It is a facultative anaerobe. It grows readily on simple nutrient media, including MacConkey agar, at 35–37°C. It is positive for catalase and oxidase reactions.[12] The organism is a common inhabitant of soil and water in tropical and subtropical regions.[3] Occasionally, it can act as an opportunistic pathogen in animals and humans and the initial skin lesion can lead to multiple liver and lung abscesses and fatal septicemia. Serious, and in some cases fatal, infections in humans have been reported from Argentina, Australia, Brazil, Cuba, Nigeria, Singapore, Taiwan, United States, and Vietnam. In most of these cases the route of entry was through the broken skin, following contamination with soil or water.[4] The organism produces a natural antibiotic called violacein (violet nondiffusable pigment), which may be useful in the treatment of colon and other cancers.[5] It was first described as a human pathogen in Malaysia in 1927.[6] The disease typically starts with a localized skin infection or localized lymphadenitis following contact with stagnant water or soil and then progresses to fulminating septicemia, with necrotizing metastatic lesions and multiple abscesses in the liver, lung, spleen, skin, lymph nodes, and brain, resulting in fatal multiorgan failure.[7] There are also reports of chronic granulomatosis, osteomyelitis, cellulitis, and periorbital and ocular infections.[2]

CASE REPORT

A 42-year-old male came with a history of a fall from the bike 7 days earlier. He had fallen into a drainage canal containing stagnant water and sustained injuries on the head and both the legs. His head and face had been submerged in the drain water. He also gave history of loss of consciousness for half an hour. He was nondiabetic and normotensive, but was a chronic smoker. After the incident he was taken to a local hospital where the wound over the scalp, measuring about 6 × 1 cm [Figure 1], was sutured and the abrasions on the legs dressed. He had been discharged with oral Ampiclox™ 500 mg TID on the following day. Over the next 5 days he developed pain and edema over the sutured area and was admitted to our hospital on the seventh day post injury.
Figure 1

Wound over the scalp

Wound over the scalp On examination, the patient was conscious and alert. His vitals were normal. Local examination showed a wound that was edematous and discharging pus. The sutures were removed and a pus sample was collected with aseptic precautions and sent to the microbiology laboratory for bacteriological culture and antimicrobial susceptibility. The routine laboratory investigations showed: hemoglobin, 13.6 g/dl; total white blood cell count of 13000 cells/mm3, with 80% neutrophils; and fasting blood sugar, 70 mg/dl. CT scan (brain) was normal. Gram stain of the discharge from the wound showed plenty of pus cells along with gram-negative pleomorphic rods. The sample was inoculated on nutrient agar, blood agar, and MacConkey agar and incubated aerobically at 37°C for 24 hours. The next day smooth, round, convex, butyrous, violet-colored colonies were noticed on all the three plates. On blood agar, deep violet colonies with beta-hemolysis was seen [Figure 2]. The organism was a facultatively anaerobic, motile, gram-negative rod. It was catalase and oxidase positive. Biochemically, indole, methyl red, and Voges-Proskauer test were negative. The organism fermented glucose (producing acid but no gas) and trehalose but did not ferment lactose or mannitol. Triple sugar iron medium showed.an alkaline slant and acid butt(K/A) without gas and H2S production. Citrate was utilized and nitrate was reduced. Arginine was decarboxylated but not lysine and ornithine. Biochemically, the isolate was identified as Chromobacterium violaceum.
Figure 2

Deep violet-colored colonies with beta-hemolysis on blood agar

Deep violet-colored colonies with beta-hemolysis on blood agar Antibiotic susceptibility of the organism was tested by the disc diffusion method [Figure 3]. The organism was found to be sensitive to gentamycin, chloramphenicol, ciprofloxacin, tetracycline, ceftazidime, imipenem, and amikacin. It showed intermediate sensitivity to cefotaxime but was resistant to penicillin and cephalexin.
Figure 3

Antibiotic susceptibility pattern of the isolate

Antibiotic susceptibility pattern of the isolate Based on the results of the antibiotic susceptibility testing, the patient was given injection gentamycin 80 mg IV twice a day for 7 days. With this treatment the wound healed completely. A repeat sample was collected the following day of first sample and the same organism was isolated again, which proved that the organism was a pathogen and not a contaminant. The patient was followed up for 15 days and the wound healed completely with no signs of recurrence or septicemia

DISCUSSION

Human infections caused by C violaceum are uncommon. Only 150 cases have been reported worldwide, including patients from Vietnam, Taiwan, Japan, United States, Brazil, Argentina, Australia, Senegal, Cuba, Nigeria, Singapore, and Sri Lanka.[24] Quick diagnosis, accurate bacterial identification, and specific treatment is very important because C violaceum may cause serious infection in healthy people. The main features in most of the cases with fatal outcome seem to be sepsis, multiple liver abscesses, and diffuse pustular dermatitis.[8]. Some studies have reported instances of untreated C violaceum causing brain abscess and diarrhea.[9] Although C violaceum generally gives rise to pigmented colonies, some nonpigmented strains have been reported, which may make diagnosis even more difficult.[10] A study by Cheong et al.[11] showed a fatal case of pulmonary C violaceum infection in an adult following aspiration of drain water. Another study from Taiwan isolated nonpigmented C violaceum from a case of bacteremic cellulitis following fish bite.[12] Similarly, the bacteria has been isolated from cases of septic spondylitis, conjunctivitis, and intra-abdominal abscess.[13-15] The organism is generally sensitive to aminoglycosides, chloramphenicol, and tetracycline and resistant to ampicillin, penicillin, and first-generation cephalosporins. Susceptibility to the newer cephalosporins is variable.[1] In our patient the following points favored the diagnosis of C violaceum: Classical history of fall into stagnant water, no response to treatment with Ampiclox™, repeat isolation of the organism from the pus sample, and response to treatment with aminoglycoside. Timely intervention, with administration of an antibiotic to which the organism was sensitive, ensured that our patient's wound healed completely and that the infection did not progress to septicemia.
  12 in total

1.  Multidrug resistant Chromobacterium violaceum: an unusual bacterium causing long standing wound abscess.

Authors:  S Dutta; S K Dutta
Journal:  Indian J Med Microbiol       Date:  2003 Jul-Sep       Impact factor: 0.985

2.  Chromobacterium violaceum septicaemia from north India.

Authors:  Pallab Ray; Jyoti Sharma; Rungmei S K Marak; S Singhi; Neelam Taneja; Raj Kumar Garg; Meera Sharma
Journal:  Indian J Med Res       Date:  2004-12       Impact factor: 2.375

Review 3.  Chromobacterium violaceum: a review of pharmacological and industiral perspectives.

Authors:  N Durán; C F Menck
Journal:  Crit Rev Microbiol       Date:  2001       Impact factor: 7.624

4.  Two cases of Chromobacterium violaceum infection after injury in a subtropical region.

Authors:  J Lee; J S Kim; C H Nahm; J W Choi; J Kim; S H Pai; K H Moon; K Lee; Y Chong
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Fatal and non-fatal chromobacterial septicemia: report of two cases.

Authors:  Y L Chou; P Y Yang; C C Huang; H S Leu; T C Tsao
Journal:  Chang Gung Med J       Date:  2000-08

6.  Nonpigmented Chromobacterium violaceum bacteremic cellulitis after fish bite.

Authors:  Ching-Huei Yang
Journal:  J Microbiol Immunol Infect       Date:  2011-01-20       Impact factor: 4.399

7.  The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

8.  Chromobacterium violaceum bacteremia: a case report.

Authors:  Chang-Hua Chen; Li-Chen Lin; Chun-Eng Liu; Tzuu-Guang Young
Journal:  J Microbiol Immunol Infect       Date:  2003-06       Impact factor: 4.399

9.  A fatal case of pulmonary chromobacterium violaceum infection in an adult.

Authors:  B M K Cheong
Journal:  Med J Malaysia       Date:  2010-06

10.  Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis.

Authors:  Günther Slesak; Phouvieng Douangdala; Saythong Inthalad; Joy Silisouk; Manivanh Vongsouvath; Amphonesavanh Sengduangphachanh; Catrin E Moore; Mayfong Mayxay; Hiroyuki Matsuoka; Paul N Newton
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-07-29       Impact factor: 3.944

View more
  10 in total

1.  The Spectrum of Chromobacterium violaceum Infections from a Single Geographic Location.

Authors:  Yi dan Lin; Suman S Majumdar; Jann Hennessy; Robert W Baird
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

2.  The Regulatory Protein ChuP Connects Heme and Siderophore-Mediated Iron Acquisition Systems Required for Chromobacterium violaceum Virulence.

Authors:  Vinicius M de Lima; Bianca B Batista; José F da Silva Neto
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

3.  Successful Treatment of Chromobacterium violaceum Sepsis in a South Indian Adult.

Authors:  Deepak R Madi; K Vidyalakshmi; John Ramapuram; Avinash K Shetty
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

4.  Identification of New Potential Inhibitors of Quorum Sensing through a Specialized Multi-Level Computational Approach.

Authors:  Fábio G Martins; André Melo; Sérgio F Sousa
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

5.  Chromobacterium violaceum Isolated from a Wound Sepsis: A Case Study from Nepal.

Authors:  Shamshul Ansari; Pramod Paudel; Kishor Gautam; Sony Shrestha; Sangita Thapa; Rajendra Gautam
Journal:  Case Rep Infect Dis       Date:  2015-12-16

6.  Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.

Authors:  Matthieu Chartier; Louis-Philippe Morency; María Inés Zylber; Rafael J Najmanovich
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-28       Impact factor: 2.483

7.  Impact of violacein from Chromobacterium violaceum on the mammalian gut microbiome.

Authors:  Heidi Pauer; Cristiane Cassiolato Pires Hardoim; Felipe Lopes Teixeira; Karla Rodrigues Miranda; Davi da Silva Barbirato; Denise Pires de Carvalho; Luis Caetano Martha Antunes; Álvaro Augusto da Costa Leitão; Leandro Araujo Lobo; Regina Maria Cavalcanti Pilotto Domingues
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

8.  Violacein-embedded nanofiber filters with antiviral and antibacterial activities.

Authors:  Jiyoung Lee; Jaehyeong Bae; Doo-Young Youn; Jaewan Ahn; Won-Tae Hwang; Hyunae Bae; Pan Kee Bae; Il-Doo Kim
Journal:  Chem Eng J       Date:  2022-04-19       Impact factor: 16.744

Review 9.  Chromobacterium violaceum: A Review of an Unexpected Scourge.

Authors:  Bachti Alisjahbana; Josephine Debora; Evan Susandi; Guntur Darmawan
Journal:  Int J Gen Med       Date:  2021-07-09

10.  Chromobacterium violaceum- induced sepsis and multiorgan dysfunction, resembling melioidosis in an elderly diabetic patient: A case report with review of literature.

Authors:  Sagar Khadanga; Tadepalli Karuna; Dharmendra Dugar; Shakti Prasad Satapathy
Journal:  J Lab Physicians       Date:  2017 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.